| Title |
FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status
|
|---|---|
| Published in |
Journal of Neuro-Oncology, April 2007
|
| DOI | 10.1007/s11060-007-9377-4 |
| Pubmed ID | |
| Authors |
Gentian Kaloshi, Karima Mokhtari, Catherine Carpentier, Sophie Taillibert, Julie Lejeune, Yannick Marie, Jean-Yves Delattre, Roseline Godbout, Marc Sanson |
| Abstract |
FABP7 expression has been analysed in a series of 123 glioblastomas (68 pure GBM, 55 GBMO, i.e. with oligodendroglial component). FABP7, found in 91/123 samples, showed a pure cytoplasmic expression in 69 cases, and cytoplasmic+nuclear expression in 22 cases. FABP7 expression was associated with pure GBM histology and shorter survival (15.7 months versus 21.5 months). Nuclear expression of FABP7 was more specifically related to EGFR amplification and more invasive tumors. These data, although they need to be confirmed by further studies, support the relation between FABP7, astrocytic features, invasion and poor prognosis and suggests that EGFR amplification is associated with nuclear translocation of FABP7. |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 2 | 6% |
| United States | 1 | 3% |
| United Kingdom | 1 | 3% |
| Unknown | 32 | 89% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 25% |
| Student > Master | 6 | 17% |
| Researcher | 5 | 14% |
| Student > Bachelor | 3 | 8% |
| Other | 3 | 8% |
| Other | 7 | 19% |
| Unknown | 3 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 8 | 22% |
| Biochemistry, Genetics and Molecular Biology | 7 | 19% |
| Medicine and Dentistry | 7 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 11% |
| Engineering | 2 | 6% |
| Other | 4 | 11% |
| Unknown | 4 | 11% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2016.
All research outputs
#4,696,560
of 22,788,370 outputs
Outputs from Journal of Neuro-Oncology
#483
of 2,967 outputs
Outputs of similar age
#14,472
of 76,396 outputs
Outputs of similar age from Journal of Neuro-Oncology
#2
of 14 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 76,396 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.